Picard Medical is trading 10.44% lower at $13.73, reversing after a sharp run-up; no clear company-specific catalyst has been identified.
- Shares closed at $15.33 on October 13, after gains on October 12 and October 13.
- A securities-lawsuit development was reported October 13; the motion to dismiss was filed September 28 and is scheduled for a February 9, 2027 hearing. There is no evidence it caused the decline.
- Healthcare’s reported gain does not explain the stock’s decline.